Edit |   |
---|---|
Antigenic Specificity | Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains (Diridavumab biosimilar) |
Clone | Diridavumab |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Influenza A Virus Hemagglutinin HA2 Subunit Recombinant Antibody. Diridavumab (CR6261) (INN) is a monoclonal antibody designed for the treatment of influenza A. This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson. |
Immunogen | n/a |
Other Names | Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains Recombinant Antibody, Research Grade Diridavumab, Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains Recombinant Antibody, CR-6261, CR6261, Antibody Drug Analogues, Monoclonal Antibody, YR1335, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1393659-46-5 |
Catalog # | YR1335 |
Price | please inquire |
Order / More Info | Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains (Diridavumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |